152 related articles for article (PubMed ID: 25143394)
1. Mutant huntingtin alters Tau phosphorylation and subcellular distribution.
Blum D; Herrera F; Francelle L; Mendes T; Basquin M; Obriot H; Demeyer D; Sergeant N; Gerhardt E; Brouillet E; Buée L; Outeiro TF
Hum Mol Genet; 2015 Jan; 24(1):76-85. PubMed ID: 25143394
[TBL] [Abstract][Full Text] [Related]
2. Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease.
Gratuze M; Noël A; Julien C; Cisbani G; Milot-Rousseau P; Morin F; Dickler M; Goupil C; Bezeau F; Poitras I; Bissonnette S; Whittington RA; Hébert SS; Cicchetti F; Parker JA; Samadi P; Planel E
Hum Mol Genet; 2015 Jan; 24(1):86-99. PubMed ID: 25205109
[TBL] [Abstract][Full Text] [Related]
3. Interaction of huntingtin fragments with brain membranes--clues to early dysfunction in Huntington's disease.
Suopanki J; Götz C; Lutsch G; Schiller J; Harjes P; Herrmann A; Wanker EE
J Neurochem; 2006 Feb; 96(3):870-84. PubMed ID: 16405500
[TBL] [Abstract][Full Text] [Related]
4. Is Huntington's disease a tauopathy?
Gratuze M; Cisbani G; Cicchetti F; Planel E
Brain; 2016 Apr; 139(Pt 4):1014-25. PubMed ID: 26969684
[TBL] [Abstract][Full Text] [Related]
5. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain.
Lim NK; Hung LW; Pang TY; Mclean CA; Liddell JR; Hilton JB; Li QX; White AR; Hannan AJ; Crouch PJ
Hum Mol Genet; 2014 Aug; 23(15):4051-63. PubMed ID: 24634145
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington's disease.
Liu KY; Shyu YC; Barbaro BA; Lin YT; Chern Y; Thompson LM; James Shen CK; Marsh JL
Hum Mol Genet; 2015 Mar; 24(6):1602-16. PubMed ID: 25398943
[TBL] [Abstract][Full Text] [Related]
7. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release.
Choo YS; Johnson GV; MacDonald M; Detloff PJ; Lesort M
Hum Mol Genet; 2004 Jul; 13(14):1407-20. PubMed ID: 15163634
[TBL] [Abstract][Full Text] [Related]
8. Live cell imaging and biophotonic methods reveal two types of mutant huntingtin inclusions.
Caron NS; Hung CL; Atwal RS; Truant R
Hum Mol Genet; 2014 May; 23(9):2324-38. PubMed ID: 24334607
[TBL] [Abstract][Full Text] [Related]
9. Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon aging.
Marcellin D; Abramowski D; Young D; Richter J; Weiss A; Marcel A; Maassen J; Kauffmann M; Bibel M; Shimshek DR; Faull RL; Bates GP; Kuhn RR; Van der Putten PH; Schmid P; Lotz GP
PLoS One; 2012; 7(9):e44457. PubMed ID: 22984513
[TBL] [Abstract][Full Text] [Related]
10. Preventing formation of toxic N-terminal huntingtin fragments through antisense oligonucleotide-mediated protein modification.
Evers MM; Tran HD; Zalachoras I; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Nucleic Acid Ther; 2014 Feb; 24(1):4-12. PubMed ID: 24380395
[TBL] [Abstract][Full Text] [Related]
11. Implications of Tau Dysregulation in Huntington's Disease and Potential for New Therapeutics.
Mees I; Nisbet RM; Hannan AJ; Renoir T
J Huntingtons Dis; 2023; 12(1):1-13. PubMed ID: 37092231
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J
Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146
[TBL] [Abstract][Full Text] [Related]
13. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.
Hsiao HY; Chen YC; Chen HM; Tu PH; Chern Y
Hum Mol Genet; 2013 May; 22(9):1826-42. PubMed ID: 23372043
[TBL] [Abstract][Full Text] [Related]
14. Impaired basal and running-induced hippocampal neurogenesis coincides with reduced Akt signaling in adult R6/1 HD mice.
Ransome MI; Hannan AJ
Mol Cell Neurosci; 2013 May; 54():93-107. PubMed ID: 23384443
[TBL] [Abstract][Full Text] [Related]
15. Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.
Bowles KR; Brooks SP; Dunnett SB; Jones L
PLoS One; 2015; 10(12):e0144864. PubMed ID: 26660732
[TBL] [Abstract][Full Text] [Related]
16. Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.
Schipper-Krom S; Juenemann K; Jansen AH; Wiemhoefer A; van den Nieuwendijk R; Smith DL; Hink MA; Bates GP; Overkleeft H; Ovaa H; Reits E
FEBS Lett; 2014 Jan; 588(1):151-9. PubMed ID: 24291262
[TBL] [Abstract][Full Text] [Related]
17. Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.
Ribeiro M; Rosenstock TR; Cunha-Oliveira T; Ferreira IL; Oliveira CR; Rego AC
Free Radic Biol Med; 2012 Nov; 53(10):1857-67. PubMed ID: 22982598
[TBL] [Abstract][Full Text] [Related]
18. Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease.
Ragauskas S; Leinonen H; Puranen J; Rönkkö S; Nymark S; Gurevicius K; Lipponen A; Kontkanen O; Puoliväli J; Tanila H; Kalesnykas G
PLoS One; 2014; 9(12):e113317. PubMed ID: 25469887
[TBL] [Abstract][Full Text] [Related]
19. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.
Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S
J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753
[TBL] [Abstract][Full Text] [Related]
20. Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington's disease.
Ribeiro FM; Devries RA; Hamilton A; Guimaraes IM; Cregan SP; Pires RG; Ferguson SS
Hum Mol Genet; 2014 Apr; 23(8):2030-42. PubMed ID: 24282028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]